Department of Ophthalmology, Collegium Medicum, Nicolas Copernicus University, Oftalmika Eye Hospital, Curie-Sklodowskiej 9, 85-094 Bydgoszcz, Poland.
J Cataract Refract Surg. 2010 Mar;36(3):402-6. doi: 10.1016/j.jcrs.2009.09.035.
To evaluate the clinical analgesic efficacy of 1.0 g oral acetaminophen (paracetamol) given in addition to topical anesthesia before phacoemulsification cataract surgery.
Inpatient and outpatient ophthalmology clinics, Bydgoszcz, Poland.
Consecutive patients with age-related cataract having phacoemulsification under topical anesthesia (tetracaine 0.5%) were enrolled in a prospective double-blind randomized placebo-controlled study. Patients were randomly assigned to preoperative oral administration of a placebo medication or to oral administration of 1.0 g acetaminophen. The main outcome measure was intensity of pain during and after surgery. Pain intensity was measured using a 10 cm baseline visual analog scale and a discrete 5-category verbal rating scale.
The study comprised 160 consecutive patients (80 in each group). Intraoperatively, the mean visual analog scale pain intensity score was 2.17 +/- 1.81 in the placebo group and 1.45 +/- 1.17 in the acetaminophen group and the mean verbal rating scale score, 1.11 +/- 0.73 and 0.67 +/- 0.66, respectively (P<.01). Postoperatively, the mean visual analog scale score for pain was 1.47 +/- 1.39 in the placebo group and 0.56 +/- 0.61 in the acetaminophen group and the mean verbal rating scale score, 0.94 +/- 0.79 and 0.28 +/- 0.41, respectively (P<.01). There was no significant difference in patient behavior during surgery and no significant adverse effects of acetaminophen use.
Preoperative oral administration of acetaminophen 1.0 g was effective, convenient, safe, and cost effective in reducing intraoperative and postoperative pain in phacoemulsification performed using topical anesthesia.
评估在超声乳化白内障手术前给予 1.0 克口服扑热息痛(对乙酰氨基酚)加局部麻醉的临床镇痛效果。
波兰比得哥什的住院和门诊眼科诊所。
连续患有年龄相关性白内障并接受局部麻醉(0.5%丁卡因)超声乳化的患者纳入前瞻性双盲随机安慰剂对照研究。患者被随机分配接受术前口服安慰剂药物或口服 1.0 克扑热息痛。主要观察指标为手术期间和手术后的疼痛强度。疼痛强度使用 10 厘米基线视觉模拟量表和离散 5 级言语评定量表进行测量。
该研究包括 160 例连续患者(每组 80 例)。术中,安慰剂组的平均视觉模拟量表疼痛强度评分为 2.17±1.81,扑热息痛组为 1.45±1.17,平均言语评定量表评分为 1.11±0.73 和 0.67±0.66,分别为(P<.01)。术后,安慰剂组的平均视觉模拟量表疼痛评分为 1.47±1.39,扑热息痛组为 0.56±0.61,平均言语评定量表评分为 0.94±0.79 和 0.28±0.41,分别为(P<.01)。手术期间患者行为无显著差异,扑热息痛使用无显著不良反应。
术前口服扑热息痛 1.0 克可有效、方便、安全且具有成本效益,可减少局部麻醉下超声乳化白内障手术中的术中及术后疼痛。